Jazz Pharmaceuticals
JAZZ
JAZZ
303 hedge funds and large institutions have $8.03B invested in Jazz Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 119 increasing their positions, 102 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 45
48% less call options, than puts
Call options by funds: $37.8M | Put options by funds: $73.1M
55% less funds holding in top 10
Funds holding in top 10: 11 → 5 (-6)
Holders
303
Holding in Top 10
5
Calls
$37.8M
Puts
$73.1M
Top Buyers
| 1 | +$53.1M | |
| 2 | +$52.6M | |
| 3 | +$51.6M | |
| 4 |
SIG
Senator Investment Group
New York
|
+$43.9M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$43.7M |
Top Sellers
| 1 | -$47.5M | |
| 2 | -$42.1M | |
| 3 | -$36.2M | |
| 4 |
BlackRock
New York
|
-$33.8M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$31.2M |